Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care01:29

Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care

Diagnosing Pulmonary EmbolismDiagnosing pulmonary embolism (PE) involves clinical assessment and advanced imaging tests. The preferred diagnostic tool is the spiral (helical) CT scan or CT angiography (CTA), which uses intravenous contrast media to visualize the pulmonary vasculature and identify emboli.A ventilation-perfusion (V/Q) scan is an alternative for patients unable to receive contrast media. This scan includes both perfusion and ventilation scanning. Perfusion scanning involves...
Pulmonary Embolism III: Nursing Management01:27

Pulmonary Embolism III: Nursing Management

A pulmonary embolism occurs when a thrombus, amniotic fluid, tumor tissue, fat, or air embolus blocks one or more pulmonary arteries. Effective nursing management and patient education are crucial for improving outcomes and preventing recurrence.Nursing management starts with obtaining a comprehensive patient history, particularly noting any history of deep vein thrombosis (DVT). Assess for clinical manifestations, including dyspnea, chest pain, crackles, heart murmurs, and signs of right-sided...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Addition of Intra-Arterial Therapy to Immunotherapy Improves Outcomes in Unresectable Hepatocellular Carcinoma: Taiwan Multicenter Cohort Study.

Liver cancer·2026
Same author

Sebivo Ameliorated Fibrotic and Inflammatory Changes in Kidney and Heart in Animal Model of Chronic Kidney Disease.

Nephrology (Carlton, Vic.)·2026
Same author

Taiwan practical consensus for evaluation and management of small-bowel bleeding.

Journal of the Chinese Medical Association : JCMA·2026
Same author

Role of endoscopic ultrasonography or magnetic resonance imaging for screening of pancreatic cancer in low-risk individuals.

World journal of clinical oncology·2025
Same author

Bedside echogram in ischaemic bowel.

BMJ case reports·2025
Same author

Secular trends and survival impact of high proportion of curative treatments for hepatocellular carcinoma in Taiwan, 2011-2019.

Annals of hepatology·2025

Related Experiment Video

Updated: Jun 26, 2026

Application of Laparoscopic Partial Splenectomy with Total Blood Flow Occlusion in Benign Splenic Lesions
02:09

Application of Laparoscopic Partial Splenectomy with Total Blood Flow Occlusion in Benign Splenic Lesions

Published on: December 20, 2024

Partial splenic embolization: 12-month hematological effects and complications.

Horng-Yuan Wang1, Shou-Chuan Shih, Shee-Chan Lin

  • 1Division of Gastroenterology and Hepatology, Mackay Memorial Hospital, Mackay Medicine, Nursing and Management College, Taipei, Taiwan. hywang.peter@msa.hinet.net

Hepato-Gastroenterology
|December 24, 2008
PubMed
Summary

Partial splenic embolization (PSE) effectively treats thrombocytopenia and leukopenia in liver cirrhosis patients. This safe procedure offers significant hematological improvement with minimal serious complications, making it a viable option for managing low platelet and white blood cell counts.

Related Experiment Videos

Last Updated: Jun 26, 2026

Application of Laparoscopic Partial Splenectomy with Total Blood Flow Occlusion in Benign Splenic Lesions
02:09

Application of Laparoscopic Partial Splenectomy with Total Blood Flow Occlusion in Benign Splenic Lesions

Published on: December 20, 2024

Area of Science:

  • Hepatology
  • Interventional Radiology
  • Hematology

Background:

  • Liver cirrhosis frequently leads to thrombocytopenia and leukopenia.
  • Managing these hematological abnormalities is crucial for patient outcomes.

Purpose of the Study:

  • To evaluate the hematological effects of partial splenic embolization (PSE).
  • To assess immediate postoperative complications following PSE in liver cirrhosis patients.

Main Methods:

  • Retrospective review of liver cirrhosis patients with thrombocytopenia and leukopenia who underwent PSE.
  • Analysis of peripheral blood counts at baseline and multiple time points post-PSE (up to 12 months).
  • Documentation of clinically significant complications and mortality.

Main Results:

  • Significant improvements in thrombocyte and leukocyte levels were observed up to one year post-PSE (P<0.01).
  • All patients experienced fever and abdominal pain; 35% had mild additional complications, and 10% had serious complications.
  • No mortality was recorded in the study cohort.

Conclusions:

  • Partial splenic embolization is an effective treatment for thrombocytopenia and leukopenia in liver cirrhosis.
  • PSE is a safe procedure with a low rate of serious complications and no mortality.
  • PSE should be considered for managing thrombocytopenia in liver cirrhosis, especially for high-risk patients unsuitable for splenectomy.